Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery

Authors:

Abstract
Cancer antigen 19-9 (CA19-9) is widely used as a marker of pancreatic cancer tumor burden and response to therapy. Synthesis of CA19-9 and its circulating
Funding Information
  • Division of Cancer Prevention, National Cancer Institute (CA176828, CA210170, CA62924)
  • Stand Up To Cancer (SU2C-AACR-DT25-17)

This publication has 35 references indexed in Scilit: